These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 9154040)
1. Cervical screening. Rate of diagnosis of cytological abnormalities is best end point. Williamson S; Wadehra V BMJ; 1997 Apr; 314(7089):1277. PubMed ID: 9154040 [No Abstract] [Full Text] [Related]
3. [The case against cytological mass screening for cervical cancer in Israel]. Menczer J Harefuah; 1992 Jun; 122(12):802-4. PubMed ID: 1505832 [No Abstract] [Full Text] [Related]
4. Cytology alone versus cytology and cervicography for cervical cancer screening: a randomized study. Ayres AW Obstet Gynecol; 1999 Jul; 94(1):159-60. PubMed ID: 10389742 [No Abstract] [Full Text] [Related]
5. Problems of cytological screening in a young urban population. Savage EW; Chapman GW Urban Health; 1977 Mar; 6(2):31, 33-4. PubMed ID: 10235788 [No Abstract] [Full Text] [Related]
6. Cervical screening. Large mismatch exists between cancers and surrogate end points. Anderson CM BMJ; 1997 Apr; 314(7089):1277. PubMed ID: 9154041 [No Abstract] [Full Text] [Related]
8. [Testing for human papillomavirus in cervical cancer screening]. Kjaer SK Ugeskr Laeger; 2002 Jan; 164(2):173-5. PubMed ID: 11831083 [No Abstract] [Full Text] [Related]
9. [Organization and results of cytological study of women in prophylactic gynecologic examinations]. Mel nik AN; Buval tseva NA Vopr Onkol; 1980; 26(7):69-70. PubMed ID: 7405109 [No Abstract] [Full Text] [Related]
10. [Cervix cancer screening: results of a french team]. Salvat J; Slamani L; Schmidt MH Rev Med Suisse Romande; 1997 Aug; 117(8):593-6. PubMed ID: 9340713 [No Abstract] [Full Text] [Related]
11. [Follow-up of non-negative cervical cytological smears in the county of Funen]. Dahl MB; Hølund B; Sørensen B; Ahrons S; Grinsted P; Poulsen EF Ugeskr Laeger; 1998 Sep; 160(40):5798-801. PubMed ID: 9782760 [TBL] [Abstract][Full Text] [Related]
12. [Screening of cervical cancer, false negative smears]. Vassilakos P; de Marval F; Muñoz M Rev Med Suisse Romande; 1998 Jan; 118(1):97. PubMed ID: 9580199 [No Abstract] [Full Text] [Related]
13. False negative rate in mass screening for cervical cancer. Sato S; Mikino H; Matsunaga G; Yajima A Acta Cytol; 1998; 42(3):836-7. PubMed ID: 9622728 [No Abstract] [Full Text] [Related]
14. [Problem of uterine and ovarian cancer mass screening]. Ohmura M; Oda M Gan To Kagaku Ryoho; 2002 Nov; 29(11):1907-16. PubMed ID: 12465389 [TBL] [Abstract][Full Text] [Related]
15. Cervical cancer screening program of Paraná: cost-effective model in a developing country. Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718 [TBL] [Abstract][Full Text] [Related]
16. The new era of cervical cancer prevention: the end of the Pap smear? Davey DD Diagn Cytopathol; 2003 Jun; 28(6):289-90. PubMed ID: 12768631 [No Abstract] [Full Text] [Related]
17. Cervical screening--1980. Clarke EA Can Med Assoc J; 1980 Feb; 122(4):387-9. PubMed ID: 7370835 [No Abstract] [Full Text] [Related]
18. [Screening of cervical cancer, false negative vaginal smears]. Weintraub D Rev Med Suisse Romande; 1997 Nov; 117(11):921. PubMed ID: 9471658 [No Abstract] [Full Text] [Related]
19. Epidemiologists and cervical screening. Cox B N Z Med J; 1987 Sep; 100(832):603-4. PubMed ID: 3452105 [No Abstract] [Full Text] [Related]
20. Effectiveness of interventions to improve follow-up after abnormal cervical cancer screening. Yabroff KR; Kerner JF; Mandelblatt JS Prev Med; 2000 Oct; 31(4):429-39. PubMed ID: 11006069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]